Final Reminder: Act Now to Nominate Future Leadership
The Nominating Committee is actively soliciting nominees for individuals to serve in the following positions:
Second Vice President
Board Member-at-large [Over Age 45] (age 45 or older on March 28, 2022)
Board Member-at-large [Under Age 45] (younger than age 45 on March 28, 2022)
Nominee to the American Board of Orthopaedic Surgery
Nominations close on July 30. Members can review the position descriptions—including information about responsibilities, desired experience, and time commitments—as well as submit nomination(s) online.
Study: Does Regional Anesthesia in Femoral Shaft Fracture Surgery Decrease Opioid Demand?
Regional anesthesia (RA) during femoral shaft fracture surgery did not decrease postoperative opioid demand, according to a study published online in Injury. In total, 436 inpatients and outpatients were assessed. RA during inpatient surgery was associated with an increase in opioid consumption within 72 hours postoperatively compared to patients who did not receive RA (6.8 versus 8.8 opioid equivalents). Ninety-day cumulative outpatient opioid requirements were comparable in patients with and without RA. Late opioid refills were more frequent in patients who received RA.
Study: Ten-year TKA Outcomes in Patients with Rheumatoid Arthritis versus Osteoarthritis
Patients with rheumatoid arthritis (RA) who underwent total knee arthroplasty (TKA) had worse 10-year outcomes compared to TKA patients with osteoarthritis (OA), according to a study published online in Knee Surgery, Sports Traumatology, Arthroscopy. Ninety TKAs in patients with RA and 180 TKAs in patients with OA were retroactively assessed. Ten-year mean Knee Society Scores across RA and OA patients increased from between 37.7 and 38.2 preoperatively to between 72.9 and 83.1 postoperatively. More patients with OA versus RA were outdoor ambulatory at final follow-up (79.2 percent versus 96.3 percent). Mortality was 15.8 percent versus 4.4 percent at final follow-up.
Study: Revision THA with Flying Buttress Tantalum Augments for Superolateral Acetabular Defects
A study of patients with superolateral acetabular defects published online in The Journal of Arthroplasty found favorable midterm survivorship and outcomes of revision total hip arthroplasty (THA) with porous tantalum augments placed in the flying buttress (type I) configuration. Fifty-nine revision THA cases with type I augments were retrospectively assessed. At eight years, mean Oxford hip scores improved from 15.9 ± 6.2 preoperatively to 35.0 ± 6.5 postoperatively. More than 95 percent of patients showed at least one sign of osseointegration via radiograph. Ten-year survivorship was 88.8 percent for all-cause revision and 94.3 percent for acetabular aseptic loosening.
Study: Favorable Outcomes of Minimally Invasive Chevron-Akin Osteotomy for Hallux Valgus
A retrospective study published online in Foot & Ankle International found favorable outcomes and low postoperative narcotic use after minimally invasive chevron-Akin osteotomy for treatment of hallux valgus deformity. Overall, 274 feet (n = 248) were assessed. Mean intermetatarsal angle improved from 13.4 degrees to 4.9 degrees pre- and postoperatively. Mean hallux valgus angle improved from 29.1 degrees to 8.9 degrees. Mean Foot Function Index part A score improved from 92 to 43. Three-day postoperative use of oxycodone was a mean of 2.2 pills.
AAOS members will soon receive the print edition of the July issue of AAOS Now, but the electronic edition is already available on the AAOS Now website. This month’s issue highlights trends in outpatient total hip arthroplasty, implicit bias in orthopaedics, a special message from AAOS President Daniel K. Guy, MD, FAAOS, about the upcoming Annual Meeting in San Diego, and more.
AAOS Board of Directors Approve CPG and AUC for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery
The AAOS Board of Directors approve a new clinical practice guideline (CPG) and an Appropriate Use Criteria (AUC) for the Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery. This CPG and AUC are one of six developed in collaboration with the Major Extremity Trauma Research Consortium and funded by a Department of Defense Grant. The CPG evaluates therapeutic interventions for pain alleviation, improved function, and less opioid use after musculoskeletal injury or orthopaedic surgery. The AUC online tool aids in determining the appropriateness of perioperative pain management in adults with orthopaedic trauma.
